Horizon Therapeutics Public Current Ratio 2009-2021 | HZNP

Current and historical current ratio for Horizon Therapeutics Public (HZNP) from 2009 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Horizon Therapeutics Public current ratio for the three months ending June 30, 2021 was 2.55.
Horizon Therapeutics Public Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $2.18B $0.85B 2.55
2021-03-31 $1.83B $0.77B 2.37
2020-12-31 $3.07B $0.88B 3.51
2020-09-30 $2.73B $0.78B 3.49
2020-06-30 $1.49B $0.99B 1.51
2020-03-31 $1.41B $0.59B 2.39
2019-12-31 $1.69B $0.72B 2.33
2019-09-30 $1.48B $0.64B 2.33
2019-06-30 $1.40B $0.64B 2.20
2019-03-31 $1.56B $0.90B 1.74
2018-12-31 $1.55B $0.71B 2.18
2018-09-30 $1.34B $0.69B 1.94
2018-06-30 $1.24B $0.73B 1.70
2018-03-31 $1.19B $0.76B 1.56
2017-12-31 $1.27B $0.80B 1.60
2017-09-30 $1.16B $0.71B 1.64
2017-06-30 $1.10B $0.68B 1.61
2017-03-31 $1.20B $0.72B 1.67
2016-12-31 $1.05B $0.61B 1.73
2016-09-30 $1.12B $0.56B 2.01
2016-06-30 $0.94B $0.42B 2.24
2016-03-31 $0.88B $0.44B 1.98
2015-12-31 $1.11B $0.36B 3.09
2015-09-30 $0.95B $0.32B 2.97
2015-06-30 $0.90B $0.29B 3.09
2015-03-31 $0.74B $0.20B 3.75
2014-12-31 $0.33B $0.22B 1.49
2014-09-30 $0.36B $0.28B 1.31
2014-06-30 $0.20B $0.20B 0.97
2014-03-31 $0.16B $0.07B 2.34
2013-12-31 $0.11B $0.04B 2.56
2013-09-30 $0.09B $0.05B 1.89
2013-06-30 $0.09B $0.04B 1.99
2013-03-31 $0.10B $0.04B 2.55
2012-12-31 $0.12B $0.04B 3.17
2012-09-30 $0.14B $0.03B 4.39
2012-06-30 $0.07B $0.03B 2.72
2012-03-31 $0.09B $0.02B 4.29
2011-12-31 $0.03B $0.02B 1.04
2011-09-30 $0.04B $0.02B 2.51
2011-06-30 $0.01B $0.03B 0.21
2011-03-31 $0.00B 0.00
2010-12-31 $0.00B 0.00
2010-09-30 $0.00B 0.00
2010-06-30 $0.00B 0.00
2009-12-31 $0.01B $0.01B 0.89
2008-12-31 $0.01B $0.02B 0.96
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $24.839B $2.200B
Horizon Therapeutics PLC is a biopharmaceutical company. It is focused on identifying, developing, acquiring and commercializing differentiated and accessible medicines which address unmet medical needs. The Company markets medicines through its orphan, rheumatology and primary care business units. Horizon Therapeutics PLC, formerly known as Horizon Pharma Public Limited Company, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71